Adeline Ruyssen‐Witrand

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Josef S Smolen, Robert Landewé, J. W. J. Bijlsma et al. · Annals of the Rheumatic Diseases · 2020 · 2.8K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study

Sandra Guignard, Laure Gossec, Carine Salliot et al. · Annals of the Rheumatic Diseases · 2006 · 225 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism

Yannick Degboé, Benjamin Rauwel, Michel Baron et al. · Frontiers in Immunology · 2019 · 168 citations · Full text

Medicine, Immunology, Pharmacology +17

Infections during tumour necrosis factor-  blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients

Carine Salliot, Laure Gossec, Adeline Ruyssen‐Witrand et al. · Lara D. Veeken · 2006 · 167 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers.

Adeline Ruyssen‐Witrand, Laure Gossec, Carine Salliot et al. · PubMed · 2007 · 127 citations

Medicine, Orthopaedic Surgery, Surgery +12